Later-Line Treatment with Lorlatinib in ALK- and...

Pharmaceuticals 2020 / 11 Vol. 13; Iss. 11

Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis

Hochmair, Maximilian J., Fabikan, Hannah, Illini, Oliver, Weinlinger, Christoph, Setinek, Ulrike, Krenbek, Dagmar, Prosch, Helmut, Rauter, Markus, Schumacher, Michael, Wöll, Ewald, Wass, Romana, Breh
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Journal:
Pharmaceuticals
DOI:
10.3390/ph13110371
Date:
November, 2020
File:
PDF, 949 KB
2020
Conversion to is in progress
Conversion to is failed